Untitled - The Addi and Cassi Fund
I. Statement Requesting Orphan Drug Designation for Use of. Hydroxy-Propyl-Beta-Cyclodextrin in the Treatment of Niemann. Pick Disease Type C.
I. Statement Requesting Orphan Drug Designation for Use of. Hydroxy-Propyl-Beta-Cyclodextrin in the Treatment of Niemann. Pick Disease Type C.